Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
16.14Prev. Close
15.80Volume
233Total traded value
0.00 CrUpper Circuit
17.38Lower Circuit
14.22Fundamentals
| Market Cap | ₹16Cr |
| ROE | 8.32% |
| P/E Ratio(TTM) | -13.39 |
| EPS(TTM) | -1.18 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.62 |
| Book Value | -14.79 |
| Debt to Equity | -1.45 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Norris Medicines
Norris Medicines is a healthcare company specializing in contract manufacturing for large multinational and Indian pharmaceutical firms. The company focuses on increasing volume and improving efficiency by implementing robust cost reduction methods and strengthening its quality standards. Notably, both of the company's manufacturing plants are WHO GMP approved, ensuring high-quality production standards.;
| Parent Organisation | Norris Medicines Limited |
| BSE Symbol | 524414 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |